Could antiretrovirals be treating EBV in MS? A case report
We present the case of an HIV-negative patient clinically diagnosed with relapsing-remitting MS who achieved significant disease improvement on Combivir (zidovudine/lamivudine). Within months of treatment, the patient reported complete resolution of previously unremitting fatigue and paresthesiae, w...
Main Authors: | Drosu, Natalia (Contributor), Edelman, Elazer R (Contributor), Housman, David E (Contributor) |
---|---|
Other Authors: | Institute for Medical Engineering and Science (Contributor), Harvard University- (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor) |
Format: | Article |
Language: | English |
Published: |
2018-07-06T13:49:06Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Understanding the mechanism of antiretroviral nucleoside analogs as inhibitors of Epstein-Barr virus lytic DNA replication
by: Drosu, Natalia C.
Published: (2020) -
Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis
by: Franses, Joseph Wang, et al.
Published: (2014) -
Epstein–Barr virus (EBV) associated lymphoepithelioma-like cholangiocarcinoma with elevated EBV DNA titer and treated with systemic chemotherapy
by: Chen-Yang Huang, et al.
Published: (2017-03-01) -
Diagnosis of EBV-Associated Inflammatory Pseudotumor in the Spleen: A Case Report
by: DI Chebotarev, et al.
Published: (2019-09-01) -
The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients
by: Anna M. C. Friis, et al.
Published: (2010-03-01)